• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《伴有微血管侵犯的肝细胞癌的手术切缘与肝切除类型比较》

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion.

机构信息

Department of Hepatic Surgery II, Third Affiliated Hospital of Naval Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, People's Republic of China.

Department of Hepatic Surgery IV, Third Affiliated Hospital of Naval Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, People's Republic of China.

出版信息

Oncologist. 2023 Nov 2;28(11):e1043-e1051. doi: 10.1093/oncolo/oyad124.

DOI:10.1093/oncolo/oyad124
PMID:37196175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10628578/
Abstract

OBJECTIVE

The objective of this study was to investigate the impact of surgical margin and hepatic resection on prognosis and compare their importance on prognosis in patients with hepatocellular carcinoma (HCC).

METHODS

The clinical data of 906 patients with HCC who underwent hepatic resection in our hospital from January 2013 to January 2015 were collected retrospectively. All patients were divided into anatomical resection (AR) (n = 234) and nonanatomical resection (NAR) group (n = 672) according to type of hepatic resection. The effects of AR and NAR and wide and narrow margins on overall survival (OS) and time to recurrence (TTR) were analyzed.

RESULTS

In all patients, narrow margin (1.560, 1.278-1.904; 1.387, 1.174-1.639) is an independent risk factor for OS and TTR, and NAR is not. Subgroup analysis showed that narrow margins (2.307, 1.699-3.132; 1.884, 1.439-2.468), and NAR (1.481, 1.047-2.095; 1.372, 1.012-1.860) are independent risk factors for OS and TTR in patients with microvascular invasion (MVI)-positive. Further analysis showed that for patients with MVI-positive HCC, NAR with wide margins was a protective factor for OS and TTR compared to AR with narrow margins (0.618, 0.396-0.965; 0.662, 0.448-0.978). The 1, 3, and 5 years OS and TTR rate of the two group were 81%, 49%, 29% versus 89%, 64%, 49% (P = .008) and 42%, 79%, 89% versus 32%, 58%, 74% (P = .024), respectively.

CONCLUSIONS

For patients with MVI-positive HCC, AR and wide margins were protective factors for prognosis. However, wide margins are more important than AR on prognosis. In the clinical setting, if the wide margins and AR cannot be ensured at the same time, the wide margins should be ensured first.

摘要

目的

本研究旨在探讨手术切缘和肝切除术对肝癌(HCC)患者预后的影响,并比较两者对预后的重要性。

方法

回顾性收集 2013 年 1 月至 2015 年 1 月我院行肝切除术的 906 例 HCC 患者的临床资料。所有患者根据肝切除术类型分为解剖性肝切除术(AR)(n=234)和非解剖性肝切除术(NAR)组(n=672)。分析 AR 和 NAR 以及宽切缘和窄切缘对总生存期(OS)和无复发生存期(TTR)的影响。

结果

在所有患者中,窄切缘(1.560,1.278-1.904;1.387,1.174-1.639)是 OS 和 TTR 的独立危险因素,而 NAR 则不是。亚组分析显示,窄切缘(2.307,1.699-3.132;1.884,1.439-2.468)和 NAR(1.481,1.047-2.095;1.372,1.012-1.860)是微血管侵犯(MVI)阳性患者 OS 和 TTR 的独立危险因素。进一步分析显示,对于 MVI 阳性 HCC 患者,与 AR 窄切缘相比,NAR 宽切缘是 OS 和 TTR 的保护因素(0.618,0.396-0.965;0.662,0.448-0.978)。两组的 1、3、5 年 OS 和 TTR 率分别为 81%、49%、29%比 89%、64%、49%(P=0.008)和 42%、79%、89%比 32%、58%、74%(P=0.024)。

结论

对于 MVI 阳性 HCC 患者,AR 和宽切缘是预后的保护因素。然而,宽切缘对预后的重要性大于 AR。在临床实践中,如果不能同时保证宽切缘和 AR,应首先保证宽切缘。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/50d0b7d95750/oyad124_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/dd29a9d92480/oyad124_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/1d79bb015a17/oyad124_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/50d0b7d95750/oyad124_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/dd29a9d92480/oyad124_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/1d79bb015a17/oyad124_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/10628578/50d0b7d95750/oyad124_fig3.jpg

相似文献

1
The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion.《伴有微血管侵犯的肝细胞癌的手术切缘与肝切除类型比较》
Oncologist. 2023 Nov 2;28(11):e1043-e1051. doi: 10.1093/oncolo/oyad124.
2
Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study.HBV 相关肝细胞癌伴微血管侵犯患者的解剖性切除和切缘状态的意义:一项多中心倾向评分匹配研究。
Int J Surg. 2023 Apr 1;109(4):679-688. doi: 10.1097/JS9.0000000000000204.
3
Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.无肉眼可见血管侵犯的孤立性肝细胞癌的解剖性切除与非解剖性切除:一项倾向评分匹配分析
J Gastroenterol Hepatol. 2017 Apr;32(4):870-878. doi: 10.1111/jgh.13603.
4
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.多中心倾向评分分析肝切除术类型对早期肝细胞癌的意义。
Hepatol Int. 2024 Apr;18(2):623-635. doi: 10.1007/s12072-023-10602-0. Epub 2023 Oct 25.
5
Comparison of anatomic and non-anatomic resections for very early-stage hepatocellular carcinoma: The importance of surgical resection margin width in non-anatomic resection.非常早期肝细胞癌的解剖性和非解剖性切除术比较:非解剖性切除中手术切缘宽度的重要性。
Surg Oncol. 2021 Mar;36:15-22. doi: 10.1016/j.suronc.2020.11.009. Epub 2020 Nov 20.
6
The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.根治性切除术后切缘和微血管侵犯对肝癌长期预后的影响:多机构研究。
HPB (Oxford). 2019 Aug;21(8):962-971. doi: 10.1016/j.hpb.2018.11.005. Epub 2019 Feb 2.
7
Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma.精确肝蒂解剖在肝细胞癌患者解剖性切除中的预后价值。
Medicine (Baltimore). 2020 Mar;99(10):e19475. doi: 10.1097/MD.0000000000019475.
8
Impact of anatomic resection on long-term survival in patients with hepatocellular carcinoma with T1-T2 disease or microscopic vascular invasion.解剖性切除术对 T1-T2 期或微小血管侵犯的肝细胞癌患者长期生存的影响。
Surg Oncol. 2023 Aug;49:101951. doi: 10.1016/j.suronc.2023.101951. Epub 2023 May 18.
9
Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.解剖性切除及宽切缘在伴有肿瘤周围微转移的肝细胞癌肝切除术中起着重要作用。
ANZ J Surg. 2019 Nov;89(11):E482-E486. doi: 10.1111/ans.15396. Epub 2019 Oct 16.
10
Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.低肿瘤标志物表达的小肝细胞癌从解剖性切除中获益更多,而不是从具有侵袭性生物学行为的肿瘤中获益。
Ann Surg. 2019 Mar;269(3):511-519. doi: 10.1097/SLA.0000000000002486.

引用本文的文献

1
An easily machine learning-based tool for preliminary risk assessment of microvascular invasion in hepatocellular carcinoma.一种基于机器学习的简易工具,用于肝细胞癌微血管侵犯的初步风险评估。
Surg Endosc. 2025 Aug 27. doi: 10.1007/s00464-025-12094-5.
2
Preoperative prediction model of microvascular invasion in intrahepatic cholangiocarcinoma patients based on CT radiomics can assist clinical surgical decision-making: a multicenter study.基于CT影像组学的肝内胆管癌患者微血管侵犯术前预测模型可辅助临床手术决策:一项多中心研究
Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11900-x.
3
The role of prognostic nutrition index in the prognosis of patients with advanced hepatocellular carcinoma who received first-line therapy.

本文引用的文献

1
Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.同期与分期行 3 段以上肝切除术治疗结直肠肝转移同步性多病灶的效果:系统评价和荟萃分析。
Cancer Rep (Hoboken). 2022 Aug;5(8):e1617. doi: 10.1002/cnr2.1617. Epub 2022 Jun 26.
2
Laparoscopic Anatomical Versus Non-anatomical hepatectomy in the Treatment of Hepatocellular Carcinoma: A randomised controlled trial.腹腔镜解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的随机对照试验。
Int J Surg. 2022 Jun;102:106652. doi: 10.1016/j.ijsu.2022.106652. Epub 2022 May 4.
3
预后营养指数在接受一线治疗的晚期肝细胞癌患者预后中的作用。
BMC Cancer. 2025 Aug 2;25(1):1258. doi: 10.1186/s12885-025-14672-1.
4
Robotic vs laparoscopic resection for hepatocellular carcinoma: multicentric propensity-score matched analysis of surgical and oncologic outcomes in 647 patients.肝细胞癌的机器人手术与腹腔镜手术切除:647例患者手术及肿瘤学结局的多中心倾向评分匹配分析
Updates Surg. 2025 Jul 20. doi: 10.1007/s13304-025-02293-z.
5
Assessment prior to liver tumor resection: what a radiologist needs to know.肝肿瘤切除术前评估:放射科医生需要了解的内容。
Abdom Radiol (NY). 2025 Jun 23. doi: 10.1007/s00261-025-05078-5.
6
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
7
The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma.酪氨酸激酶抑制剂和程序性细胞死亡蛋白1抑制剂联合肝动脉灌注化疗/经动脉化疗栓塞术治疗复发性不可切除肝细胞癌的安全性和疗效
BMC Cancer. 2025 Apr 25;25(1):779. doi: 10.1186/s12885-025-14185-x.
8
Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.肝细胞-胆管细胞癌的临床病理及超声特征及其与微血管侵犯的相关性:超声造影的预测作用
Front Oncol. 2024 Dec 20;14:1474675. doi: 10.3389/fonc.2024.1474675. eCollection 2024.
9
Case report: Outflow reconstruction with pre-frozen allograft blood vessels during partial hepatectomy followed by tumor resection and partial liver autotransplantation for locally advanced hepatocellular carcinoma with background of cirrhosis.病例报告:在部分肝切除术中使用预冻同种异体血管进行流出道重建,随后进行肿瘤切除和部分肝脏自体移植治疗伴有肝硬化背景的局部晚期肝细胞癌。
Front Oncol. 2024 Dec 13;14:1432274. doi: 10.3389/fonc.2024.1432274. eCollection 2024.
10
Clinical Nomogram Model for Pre-Operative Prediction of Microvascular Invasion of Hepatocellular Carcinoma before Hepatectomy.临床列线图模型预测肝癌切除术前行微血管侵犯的术前预测。
Medicina (Kaunas). 2024 Aug 28;60(9):1410. doi: 10.3390/medicina60091410.
Effects of Anatomical or Non-Anatomical Resection of Hepatocellular Carcinoma on Survival Outcome.
肝细胞癌解剖性或非解剖性切除对生存结局的影响。
J Clin Med. 2022 Mar 2;11(5):1369. doi: 10.3390/jcm11051369.
4
Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection.微血管侵犯风险和肿瘤大小对肝细胞癌解剖性切除和非解剖性切除后复发及生存的重要性
Front Oncol. 2021 Mar 17;11:621622. doi: 10.3389/fonc.2021.621622. eCollection 2021.
5
Anatomic versus non-anatomic resection of hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.解剖性与非解剖性肝切除术治疗合并微血管侵犯的肝细胞癌:系统评价和荟萃分析。
Asian J Surg. 2021 Sep;44(9):1143-1150. doi: 10.1016/j.asjsur.2021.02.023. Epub 2021 Mar 23.
6
Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis.解剖性与非解剖性肝切除术治疗肝细胞癌,我们有答案吗?一项荟萃分析。
Int J Surg. 2020 Aug;80:243-255. doi: 10.1016/j.ijsu.2020.05.008. Epub 2020 May 13.
7
Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.单发肝细胞癌手术切除边界的意义。
Br J Surg. 2020 Jan;107(1):113-120. doi: 10.1002/bjs.11329. Epub 2019 Oct 25.
8
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
9
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.基于增强 CT 的影像组学分析预测肝细胞癌的微血管侵犯及预后
J Hepatol. 2019 Jun;70(6):1133-1144. doi: 10.1016/j.jhep.2019.02.023. Epub 2019 Mar 13.
10
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.肝细胞癌微血管侵犯的预后和治疗意义。
Ann Surg Oncol. 2019 May;26(5):1474-1493. doi: 10.1245/s10434-019-07227-9. Epub 2019 Feb 20.